Literature DB >> 21623199

Screening for NLRP7 mutations in familial and sporadic recurrent hydatidiform moles: report of 2 Tunisian families.

Hanène Landolsi1, Cécile Rittore, Laurent Philibert, Nabiha Missaoui, Sihem Hmissa, Isabelle Touitou, Moez Gribaa, Mohamed Tahar Yacoubi.   

Abstract

A familial or sporadic recurrent hydatidiform mole is a rare autosomal recessive condition that has been associated with biallelic mutations in the nucleotide-binding, leucine-rich repeat, pyrin domain 7 (NLRP7) gene (19q13.42). Cases from different ethnic origins have been reported earlier. Here we report the first Tunisian patients: 2 sisters with homozygous NLRP7 mutations (p.E570X) and 1 sporadic case with no mutation in NLRP7. Our results extend the number of familial recurrent reproductive wastages due to mutations in NLRP7. We suggest that mutations screening of NLRP7 could be proposed more systematically in women with recurrent pathologic pregnancy outcomes of unknown origin. The rare cases with a typical clinical picture, which were not related to NLRP7 mutation as in our sporadic case, should be investigated more to identify the causative gene.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21623199     DOI: 10.1097/PGP.0b013e31820dc3b0

Source DB:  PubMed          Journal:  Int J Gynecol Pathol        ISSN: 0277-1691            Impact factor:   2.762


  8 in total

1.  Mutations causing familial biparental hydatidiform mole implicate c6orf221 as a possible regulator of genomic imprinting in the human oocyte.

Authors:  David A Parry; Clare V Logan; Bruce E Hayward; Michael Shires; Hanène Landolsi; Christine Diggle; Ian Carr; Cécile Rittore; Isabelle Touitou; Laurent Philibert; Rosemary A Fisher; Masoumeh Fallahian; John D Huntriss; Helen M Picton; Saghira Malik; Graham R Taylor; Colin A Johnson; David T Bonthron; Eamonn G Sheridan
Journal:  Am J Hum Genet       Date:  2011-09-01       Impact factor: 11.025

2.  Report of four new patients with protein-truncating mutations in C6orf221/KHDC3L and colocalization with NLRP7.

Authors:  Ramesh Reddy; Elie Akoury; Ngoc Minh Phuong Nguyen; Omar A Abdul-Rahman; Christine Dery; Neerja Gupta; William P Daley; Asangla Ao; Hanene Landolsi; Rosemary Ann Fisher; Isabelle Touitou; Rima Slim
Journal:  Eur J Hum Genet       Date:  2012-12-12       Impact factor: 4.246

3.  Maternal heterozygous NLRP7 variant results in recurrent reproductive failure and imprinting disturbances in the offspring.

Authors:  Lukas Soellner; Matthias Begemann; Franziska Degenhardt; Annegret Geipel; Thomas Eggermann; Elisabeth Mangold
Journal:  Eur J Hum Genet       Date:  2017-05-31       Impact factor: 4.246

Review 4.  NLRP7: From inflammasome regulation to human disease.

Authors:  Jessica Carriere; Andrea Dorfleutner; Christian Stehlik
Journal:  Immunology       Date:  2021-06-30       Impact factor: 7.215

5.  Hepatic toxicity following actinomycin D chemotherapy in treatment of familial gestational trophoblastic neoplasia: A case report.

Authors:  Xiyan Mu; Rutie Yin; Danqing Wang; Liang Song; Yu Ma; Xia Zhao; Qingli Li
Journal:  Medicine (Baltimore)       Date:  2018-09       Impact factor: 1.817

6.  High-Risk Gestational Trophoblastic Neoplasia from a Homozygous NLRP7 Mutation.

Authors:  Zachary A Kopelman; Erica R Hope
Journal:  Gynecol Oncol Rep       Date:  2021-06-06

7.  NLRP7 and the Genetics of Hydatidiform Moles: Recent Advances and New Challenges.

Authors:  Rima Slim; Evan P Wallace
Journal:  Front Immunol       Date:  2013-08-20       Impact factor: 7.561

Review 8.  Genetics and Epigenetics of Recurrent Hydatidiform Moles: Basic Science and Genetic Counselling.

Authors:  Ngoc Minh Phuong Nguyen; Rima Slim
Journal:  Curr Obstet Gynecol Rep       Date:  2014-01-21
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.